Analysis of risk factors related to pneumonia after multidrug-resistant bacterial infection and exploration of control methodology
-
摘要:
目的 通过监测胸外科术后肺炎医院感染的发生情况,分析多重耐药菌感染所致术后肺炎的相关危险因素,从而制定相应防控和干预措施,以降低术后肺炎感染发生率及多重耐药菌感染所致的术后肺炎发生率,有效加速患者术后康复。 方法 通过对2016—2018年入住胸外科的所用手术患者610例进行医院感染目标性监测,分析多重耐药菌感染所致术后肺炎发生情况及感染相关危险因素。采用SPSS 20.0软件对数据进行统计分析。 结果 检出铜绿假单胞菌最多:共22株,占比50.00%(22/44)。检出的多重耐药菌主要为:耐碳青霉烯鲍曼不动杆菌共8株,占比53.33%(8/15)。多重耐药菌感染导致的术后肺炎感染率呈现下降趋势,从2016年的3.38%降至2018年的1.37%,对其危险因素进行单因素分析发现:抗生素使用≥14 d、留置导尿管、进行机械通气、入住重症监护病房、ASA评分≥Ⅱ、使用抗菌药物种类≥3种等因素是主要危险因素(均P<0.05),经logistic多因素分析结果发现,仅抗生素使用时间是多重耐药菌感染所致术后肺炎感染的相关独立危险因素。 结论 通过有效的医院感染监测及危险因素分析,可发现多重耐药菌感染所致术后肺炎的主要感染危险因素,从而降低多重耐药菌感染所致术后肺炎的发生率。 Abstract:Objective This study aimed to monitor the incidence of nosocomial pneumonia caused by multidrug-resistant bacteria after thoracic surgery; analyse the risk factors of postoperative pneumonia caused by multidrug-resistant bacteria; develop corresponding prevention, control and intervention measures and reduce the incidence of postoperative pneumonia and multidrug-resistant bacterial infection, thereby accelerating the postoperative recovery of patients. Methods A total of 610 patients were admitted to the Department of Thoracic Surgery from 2016 to 2018 and monitored for nosocomial infection, and the incidence of postoperative pneumonia caused by multidrug-resistant bacterial infection and the risk factors associated with infection were analysed. SPSS 20.0 software was used for statistical analysis of data. Results A total of 22 strains of Pseudomonas aeruginosa were detected, accounting for 50.00% (22/44), and 8 strains of carbapenem-resistant Acinetobacter baumannii were detected, accounting for 53.33% (8/15). The rate of postoperative pneumonia caused by multidrug-resistant bacterial infection decreased from 3.38% in 2016 to 1.37% in 2018, and single-factor analysis showed the following risk factors: antibiotic use for 14 days, urethral catheter or mechanical ventilation. The length of stay in intensive care unit, ASA score acuity Ⅱ and use of antimicrobial agents are the main risk factors (all P < 0.05). Logistic multifactor analysis showed that only antibiotic use was the related independent risk factor of postoperative pneumonia caused by multidrug-resistant bacterial infection. Conclusion The main risk factors of postoperative pneumonia caused by multidrug-resistant bacterial infection can be found through effective nosocomial infection monitoring and risk factor analysis, thereby reducing the incidence of postoperative pneumonia caused by multidrug-resistant bacterial infection. -
Key words:
- Postoperative pneumonia /
- Multidrug-resistant bacteria /
- Risk factors
-
表 1 2016—2018年胸外科POP感染发生率[例(%)]
年份 手术例数 MDRO感染所致POP 总POP感染 2016 207 7(3.38) 20(9.66) 2017 184 5(2.72) 13(7.07) 2018 219 3(1.37) 10(4.57) 合计 610 15(2.46) 43(7.05) 表 2 POP主要感染病原菌分布
病原菌 株数 MDRO(例) 铜绿假单胞菌 22 7 鲍曼不动杆菌 12 8 肺炎克雷伯杆菌 4 0 粘质沙雷菌 2 0 奇异变形菌 2 0 大肠埃希菌 1 0 阴沟肠杆菌 1 0 合计 44 15 注:研究的43例POP患者共检出44株细菌,其中1例POP患者检出2株致病菌。 表 3 MDRO感染所致POP的危险因素的单因素分析结果(例)
因素 特征 POP MDRO 非MDRO χ2值 P值 年龄(岁) ≥60 23 9 14 0.393 0.531 < 60 20 6 14 性别 男 30 12 18 1.144 0.285 女 13 3 10 糖尿病史 有 12 5 7 0.337 0.561 无 31 10 21 感染前住院(d) ≥7 33 12 21 0.137 0.711 <7 10 3 7 入住ICU 是 12 7 5 4.029 0.045 否 31 8 23 PICC 有 27 11 16 1.096 0.295 无 16 4 12 机械通气 有 9 7 2 9.22 0.002 无 34 8 26 留置导尿 有 29 7 22 4.528 0.033 无 14 8 6 使用免疫抑制剂 是 13 5 8 0.105 0.746 否 30 10 20 抗菌药物使用(d) ≥14 18 14 4 25.077 < 0.001 <14 25 1 24 抗菌药物种类 ≥3种 12 10 2 17.201 < 0.001 <3种 31 5 26 血糖(mmol/L) >11.1 3 2 1 1.434 0.231 ≤11.1 40 13 27 血清白蛋白(g/L) <30 11 4 7 0.014 0.905 ≥30 32 11 21 高血压 是 10 4 6 0.150 0.698 否 33 11 22 吸烟史 是 20 8 12 0.431 0.512 否 23 7 16 ASA分级 Ⅰ 15 5 10 25.973 < 0.001 ≥Ⅱ 28 10 18 -
[1] 张新玉, 安帅, 黄江, 等. 髋部骨折患者术后新发肺部感染的危险因素分析[J]. 北京医学, 2018, 40(1): 19-22. https://www.cnki.com.cn/Article/CJFDTOTAL-BJYX201801007.htm [2] 池水晶, 封燚, 李慧, 等. 数字化院感监控有效控制术后肺炎方法探究[J]. 河北医学, 2020, 26(6): 1048-1053. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX202006038.htm [3] 洪燕, 郭海萍, 陈金连, 等. 某院恶性肿瘤患者多重耐药菌感染监测及危险因素分析[J]. 中华全科医学, 2020, 18(02): 314-317. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202002041.htm [4] LUO A, PEI N, MI J, et al. Type 2 diabetes and postoperative pneumonia: An observational, population-based study using the Spanish Hospital Discharge Database, 2001-2015[J]. PLoS One, 2019, 14(2): e0211230. doi: 10.1371/journal.pone.0211230 [5] HUANG Y, JIAO Y, ZHANG J, et al. Microbial Etiology and prognostic factors of ventilator-associated pneumonia: a multicenter retrospective study in Shanghai[J]. Clin Infect Dis, 2018, 67(2): 146-152. http://www.onacademic.com/detail/journal_1000041616898199_df94.html [6] 王坤, 任琳, 王金霞, 等. 腹膜透析发生肺部感染危险因素的病例对照研究[J]. 安徽医学, 2019, 40(8): 924-927. doi: 10.3969/j.issn.1000-0399.2019.08.023 [7] 钱华, 付继京, 张淑彦, 等. 中西医综合干预对不同证型肺部多重耐药菌感染的防控效果[J]. 中国临床研究, 2018, 31(8): 1113-1116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201808027.htm [8] 吴广江, 宋清坤, 马颖欣, 等. 术后患者肺部感染危险因素的分析[J]. 北京医学, 2019, 41(5): 385-388. https://www.cnki.com.cn/Article/CJFDTOTAL-BJYX201905013.htm [9] YANG R, WU Y, YAO L, et al. Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer[J]. Ther Clin Risk Manag, 2019, 15(6): 223-231. http://www.onacademic.com/detail/journal_1000041685767299_114e.html [10] 刘丁维, 魏青政, 邵圆愿. 重症肺炎患者病原菌分布与血清PCT、CRP、RAGE、sTREM-1变化分析[J]. 国际检验医学杂志, 2018, 39(19): 2369-2372. doi: 10.3969/j.issn.1673-4130.2018.19.009 [11] 贺刚, 杜飞. 初始抗生素选择对普通病房重症社区获得性肺炎患者预后的影响[J]. 现代医药卫生, 2020, 36(18): 2886-2889. doi: 10.3969/j.issn.1009-5519.2020.18.019 [12] DI H, TI M, SHI W, et al. Influence of prophylactic antibiotic duration on postoperative pneumonia following pulmonary lobectomy for non-small cell lung cancer[J]. J Thorac Dis, 2019, 11(4): 1155-1164. doi: 10.21037/jtd.2019.04.43 [13] RUSSOTTO V, SABATÉ S, CANET J. Development of a prediction model for postoperative pneumonia: A multicentre prospective observational study[J]. Eur J Anaesth, 2019, 36(2): 93-104. doi: 10.1097/EJA.0000000000000921 [14] 崔少罡, 陈维静, 常诚, 等. 抗生素在预防胸外科择期手术切口感染中的应用[J]. 中华医院感染学杂志, 1999, 10(4): 18-20. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY199904007.htm [15] KANDA M, KOIKE M, TANAKA C, et al. Risk prediction of postoperative pneumonia after subtotal esophagectomy based on preoperative serum cholinesterase concentrations[J]. Ann Surg Oncol, 2019, 26(11): 3718-3726. doi: 10.1245/s10434-019-07512-7 [16] 宗志勇, 朱仕超. 术后肺炎预防和控制专家共识[J]. 中华临床感染病杂志, 2018, 11(1): 11-19.
计量
- 文章访问数: 181
- HTML全文浏览量: 107
- PDF下载量: 6
- 被引次数: 0